Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Mar;73(5):630–635. doi: 10.1038/bjc.1996.109

Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody.

C Toulas 1, J Mihura 1, C de Balincourt 1, B Marques 1, E Marek 1, G Soula 1, H Roche 1, G Favre 1
PMCID: PMC2074342  PMID: 8605098

Abstract

The metastasis-suppressor nme gene (also called nm23), first identified in murine melanoma cells, exists as two forms in human: nme1 and nme2. However, only the lack of expression of nme1 has been related to distant metastasis appearance in human breast cancer. The aim of this work was first to raise specific antibodies to allow the analysis of Nme1 and then, with this specific tool, to evaluate the predictive value of Nme1 detection in cytosolic extracts of human breast tumours. We obtained a hen antibody that specifically reacts with Nme1 without any cross-reaction with Nme2. We analysed the expression of the protein in 59 human breast tumours and found a significant relationship between this expression and oestrogen receptor status (P<0.001). Moreover, Nme1 expression is related to metastasis-free survival (P<0.001) and survival of patients (P<0.001). The determination of Nme1 expression in primary tumours using our antibody should be an interesting predictive test of the metastasis for clinical investigations.

Full text

PDF
630

Images in this article

632Figure 1
on p.632
632Figure 2
on p.632

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami H. O., Graffman S., Lindgren A., Sällström J. Prognostic implication of estrogen receptor content in breast cancer. Breast Cancer Res Treat. 1985;5(3):293–300. doi: 10.1007/BF01806024. [DOI] [PubMed] [Google Scholar]
  2. Arai T., Watanabe M., Onodera M., Yamashita T., Masunaga A., Itoyama S., Itoh K., Sugawara I. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid. Am J Pathol. 1993 Jun;142(6):1938–1944. [PMC free article] [PubMed] [Google Scholar]
  3. Barnes R., Masood S., Barker E., Rosengard A. M., Coggin D. L., Crowell T., King C. R., Porter-Jordan K., Wargotz E. S., Liotta L. A. Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am J Pathol. 1991 Aug;139(2):245–250. [PMC free article] [PubMed] [Google Scholar]
  4. Bevilacqua G., Sobel M. E., Liotta L. A., Steeg P. S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res. 1989 Sep 15;49(18):5185–5190. [PubMed] [Google Scholar]
  5. Boix L., Bruix J., Campo E., Sole M., Castells A., Fuster J., Rivera F., Cardesa A., Rodes J. nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology. 1994 Aug;107(2):486–491. doi: 10.1016/0016-5085(94)90175-9. [DOI] [PubMed] [Google Scholar]
  6. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  7. Brown A. M., Jeltsch J. M., Roberts M., Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6344–6348. doi: 10.1073/pnas.81.20.6344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Contesso G., Mouriesse H., Friedman S., Genin J., Sarrazin D., Rouesse J. The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. J Clin Oncol. 1987 Sep;5(9):1378–1386. doi: 10.1200/JCO.1987.5.9.1378. [DOI] [PubMed] [Google Scholar]
  9. Cropp C. S., Lidereau R., Leone A., Liscia D., Cappa A. P., Campbell G., Barker E., Le Doussal V., Steeg P. S., Callahan R. NME1 protein expression and loss of heterozygosity mutations in primary human breast tumors. J Natl Cancer Inst. 1994 Aug 3;86(15):1167–1169. doi: 10.1093/jnci/86.15.1167. [DOI] [PubMed] [Google Scholar]
  10. Gassmann M., Thömmes P., Weiser T., Hübscher U. Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 1990 May;4(8):2528–2532. doi: 10.1096/fasebj.4.8.1970792. [DOI] [PubMed] [Google Scholar]
  11. Gilles A. M., Presecan E., Vonica A., Lascu I. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem. 1991 May 15;266(14):8784–8789. [PubMed] [Google Scholar]
  12. Hennessy C., Henry J. A., May F. E., Westley B. R., Angus B., Lennard T. W. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst. 1991 Feb 20;83(4):281–285. doi: 10.1093/jnci/83.4.281. [DOI] [PubMed] [Google Scholar]
  13. Henry J. A., Piggott N. H., Mallick U. K., Nicholson S., Farndon J. R., Westley B. R., May F. E. pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br J Cancer. 1991 Apr;63(4):615–622. doi: 10.1038/bjc.1991.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hirayama R., Sawai S., Takagi Y., Mishima Y., Kimura N., Shimada N., Esaki Y., Kurashima C., Utsuyama M., Hirokawa K. Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J Natl Cancer Inst. 1991 Sep 4;83(17):1249–1250. doi: 10.1093/jnci/83.17.1249. [DOI] [PubMed] [Google Scholar]
  15. Howlett A. R., Petersen O. W., Steeg P. S., Bissell M. J. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst. 1994 Dec 21;86(24):1838–1844. doi: 10.1093/jnci/86.24.1838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kimura N., Shimada N. Membrane-associated nucleoside diphosphate kinase from rat liver. Purification, characterization, and comparison with cytosolic enzyme. J Biol Chem. 1988 Apr 5;263(10):4647–4653. [PubMed] [Google Scholar]
  17. Lacombe M. L., Sastre-Garau X., Lascu I., Vonica A., Wallet V., Thiery J. P., Véron M. Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours. Eur J Cancer. 1991;27(10):1302–1307. doi: 10.1016/0277-5379(91)90101-i. [DOI] [PubMed] [Google Scholar]
  18. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  19. Leone A., McBride O. W., Weston A., Wang M. G., Anglard P., Cropp C. S., Goepel J. R., Lidereau R., Callahan R., Linehan W. M. Somatic allelic deletion of nm23 in human cancer. Cancer Res. 1991 May 1;51(9):2490–2493. [PubMed] [Google Scholar]
  20. MacDonald N. J., De la Rosa A., Benedict M. A., Freije J. M., Krutsch H., Steeg P. S. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem. 1993 Dec 5;268(34):25780–25789. [PubMed] [Google Scholar]
  21. Mandai M., Konishi I., Koshiyama M., Mori T., Arao S., Tashiro H., Okamura H., Nomura H., Hiai H., Fukumoto M. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res. 1994 Apr 1;54(7):1825–1830. [PubMed] [Google Scholar]
  22. Muss H. B., Thor A. D., Berry D. A., Kute T., Liu E. T., Koerner F., Cirrincione C. T., Budman D. R., Wood W. C., Barcos M. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med. 1994 May 5;330(18):1260–1266. doi: 10.1056/NEJM199405053301802. [DOI] [PubMed] [Google Scholar]
  23. Myeroff L. L., Markowitz S. D. Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst. 1993 Jan 20;85(2):147–152. doi: 10.1093/jnci/85.2.147. [DOI] [PubMed] [Google Scholar]
  24. Nakayama T., Ohtsuru A., Nakao K., Shima M., Nakata K., Watanabe K., Ishii N., Kimura N., Nagataki S. Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst. 1992 Sep 2;84(17):1349–1354. doi: 10.1093/jnci/84.17.1349. [DOI] [PubMed] [Google Scholar]
  25. Nickerson J. A., Wells W. W. The microtubule-associated nucleoside diphosphate kinase. J Biol Chem. 1984 Sep 25;259(18):11297–11304. [PubMed] [Google Scholar]
  27. Reiner A., Reiner G., Spona J., Schemper M., Holzner J. H. Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis. Cancer. 1988 Mar 15;61(6):1149–1154. doi: 10.1002/1097-0142(19880315)61:6<1149::aid-cncr2820610615>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  28. Rilke F., Colnaghi M. I., Cascinelli N., Andreola S., Baldini M. T., Bufalino R., Della Porta G., Ménard S., Pierotti M. A., Testori A. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer. 1991 Aug 19;49(1):44–49. doi: 10.1002/ijc.2910490109. [DOI] [PubMed] [Google Scholar]
  29. Royds J. A., Stephenson T. J., Rees R. C., Shorthouse A. J., Silcocks P. B. Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst. 1993 May 5;85(9):727–731. doi: 10.1093/jnci/85.9.727. [DOI] [PubMed] [Google Scholar]
  30. Sastre-Garau X., Lacombe M. L., Jouve M., Véron M., Magdelénat H. Nucleoside diphosphate kinase/NM23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int J Cancer. 1992 Feb 20;50(4):533–538. doi: 10.1002/ijc.2910500406. [DOI] [PubMed] [Google Scholar]
  31. Sawan A., Lascu I., Veron M., Anderson J. J., Wright C., Horne C. H., Angus B. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study. J Pathol. 1994 Jan;172(1):27–34. doi: 10.1002/path.1711720107. [DOI] [PubMed] [Google Scholar]
  32. Simpson J. F., O'Malley F., Dupont W. D., Page D. L. Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma. Cancer. 1994 May 1;73(9):2352–2358. doi: 10.1002/1097-0142(19940501)73:9<2352::aid-cncr2820730918>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  33. Slamon D. J. Expression of the nm23 gene and breast cancer prognosis. J Natl Cancer Inst. 1991 Feb 20;83(4):229–231. doi: 10.1093/jnci/83.4.229. [DOI] [PubMed] [Google Scholar]
  34. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  35. Stahl J. A., Leone A., Rosengard A. M., Porter L., King C. R., Steeg P. S. Identification of a second human nm23 gene, nm23-H2. Cancer Res. 1991 Jan 1;51(1):445–449. [PubMed] [Google Scholar]
  36. Steeg P. S., Bevilacqua G., Kopper L., Thorgeirsson U. P., Talmadge J. E., Liotta L. A., Sobel M. E. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988 Apr 6;80(3):200–204. doi: 10.1093/jnci/80.3.200. [DOI] [PubMed] [Google Scholar]
  37. Tokunaga Y., Urano T., Furukawa K., Kondo H., Kanematsu T., Shiku H. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer. 1993 Aug 19;55(1):66–71. doi: 10.1002/ijc.2910550113. [DOI] [PubMed] [Google Scholar]
  38. Wright C., Angus B., Nicholson S., Sainsbury J. R., Cairns J., Gullick W. J., Kelly P., Harris A. L., Horne C. H. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res. 1989 Apr 15;49(8):2087–2090. [PubMed] [Google Scholar]
  39. Xerri L., Grob J. J., Battyani Z., Gouvernet J., Hassoun J., Bonerandi J. J. NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival. Br J Cancer. 1994 Dec;70(6):1224–1228. doi: 10.1038/bjc.1994.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yamaguchi A., Urano T., Fushida S., Furukawa K., Nishimura G., Yonemura Y., Miyazaki I., Nakagawara G., Shiku H. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Br J Cancer. 1993 Nov;68(5):1020–1024. doi: 10.1038/bjc.1993.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Yamaguchi A., Urano T., Goi T., Takeuchi K., Niimoto S., Nakagawara G., Furukawa K., Shiku H. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer. 1994 May 1;73(9):2280–2284. doi: 10.1002/1097-0142(19940501)73:9<2280::aid-cncr2820730908>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES